Henry Schein (NASDAQ:HSIC) Updates FY24 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $5.00 to $5.16 for the period, compared to the consensus earnings per share estimate of $5.06. The company issued revenue guidance of +8-10% yr/yr or $13.326 billion to $13.573 billion from +8, compared to the consensus revenue estimate of $13.42 billion.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $0.29 during trading on Thursday, hitting $73.05. 692,152 shares of the company were exchanged, compared to its average volume of 1,103,072. The company has a market cap of $9.39 billion, a price-to-earnings ratio of 23.18, a PEG ratio of 1.68 and a beta of 0.87. Henry Schein has a 1 year low of $60.01 and a 1 year high of $82.63. The firm’s fifty day moving average price is $73.01 and its 200 day moving average price is $72.34. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 EPS. On average, sell-side analysts expect that Henry Schein will post 5.07 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on HSIC. JPMorgan Chase & Co. boosted their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an overweight rating in a research note on Wednesday, March 6th. SVB Leerink assumed coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a market perform rating and a $78.00 price objective for the company. TheStreet raised shares of Henry Schein from a c+ rating to a b- rating in a research note on Monday, February 26th. Piper Sandler upped their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an overweight rating in a research note on Monday, February 26th. Finally, Barrington Research upped their price objective on shares of Henry Schein from $90.00 to $92.00 and gave the company an outperform rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of Hold and a consensus price target of $81.73.

Insider Activity at Henry Schein

In related news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.